Abstral and Robinul drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Abstral (fentanyl citrate) and Robinul (glycopyrrolate). Common drug interactions include blood pressure decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Abstral and Robinul. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Abstral?

Abstral has active ingredients of fentanyl citrate. eHealthMe is studying from 1,390 Abstral users. Check the latest studies of Abstral.

What is Robinul?

Robinul has active ingredients of glycopyrrolate. It is often used in hyperhidrosis. eHealthMe is studying from 1,663 Robinul users. Check the latest studies of Robinul.



On Jul, 30, 2026

16 people who take Abstral and Robinul together, and have interactions are studied.

Abstral and Robinul drug interactions.

What are the common drug interactions of Abstral and Robinul, by gender? *:

female:

n/a

male:

  1. Blood pressure decreased
  2. Body temperature increased
  3. Subcutaneous abscess
  4. Chills (felling of cold)
  5. Diarrhoea
  6. Drug intolerance (drug sensitivity)
  7. General physical health deterioration (weak health status)
  8. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  9. Abscess (pus)
  10. Drug hypersensitivity

What are the common drug interactions of Abstral and Robinul, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Death

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Blood pressure decreased
  2. Body temperature increased
  3. Chills (felling of cold)
  4. Diarrhoea
  5. Drug intolerance (drug sensitivity)
  6. General physical health deterioration (weak health status)
  7. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  8. Abscess (pus)
  9. Drug hypersensitivity
  10. Subcutaneous abscess

What are the existing conditions these people have? *

  1. Laxative Supportive Care: 14 people, 87.50%
  2. Breakthrough Pain: 14 people, 87.50%
  3. Pain: 2 people, 12.50%
  4. Stress And Anxiety: 1 person, 6.25%
  5. Severe Acute Respiratory Syndrome (a serious form of pneumonia caused by virus infection): 1 person, 6.25%
  6. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 6.25%
  7. Rales (an abnormal respiratory sound characterized by fine crackles): 1 person, 6.25%
  8. Insomnia (sleeplessness): 1 person, 6.25%
  9. Increased Bronchial Secretion: 1 person, 6.25%
  10. Dyspnea (difficult or laboured breathing): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Abstral and Robinul?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Abstral and Robinul:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Abstral:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Robinul:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Abstral and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Robinul and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on fentanyl citrate and glycopyrrolate (the active ingredients of Abstral and Robinul, respectively), and Abstral and Robinul (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: